Description

This issue of Vital Signs, released on December 17, 2007, provides a strategic overview the Topical Hemostats and Tissue Sealants market. Additionally, a company spotlight is provided for Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company that develops, manufactures and markets advanced technologies and medical products for local diseases, complications associates with medical device implants, surgical interventions and acute injury. Reimbursement and regulatory news from the FDA is also provided for the week of December 3 - December 7, 2007.